DBV Technologies SA (DBVT)
0.634
+0.04
(+7.28%)
USD |
NASDAQ |
May 17, 12:36
DBV Technologies Free Cash Flow: -95.40M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -95.40M |
| December 31, 2023 | -80.33M |
| September 30, 2023 | -90.19M |
| June 30, 2023 | -90.99M |
| March 31, 2023 | -75.76M |
| December 31, 2022 | -56.42M |
| September 30, 2022 | -52.22M |
| Date | Value |
|---|---|
| June 30, 2022 | -54.75M |
| March 31, 2022 | -74.39M |
| December 31, 2021 | -109.16M |
| September 30, 2021 | -123.59M |
| June 30, 2021 | -143.65M |
| March 31, 2021 | -154.20M |
| December 31, 2020 | -168.42M |
Free Cash Flow Range, Past 5 Years
-168.42M
Minimum
Dec 2020
-52.22M
Maximum
Sep 2022
-97.82M
Average
-90.59M
Median
Free Cash Flow Benchmarks
| Cellectis SA | -25.82M |
| Biophytis SA | -14.21M |
| Edap TMS SA | -20.54M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -145.76M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.69M |
| Cash from Investing (Quarterly) | -2.132M |
| Cash from Financing (Quarterly) | -0.062M |
| Free Cash Flow Per Share (Quarterly) | -0.1873 |
| Free Cash Flow Yield | -78.65% |